Association of Neonatal Morbidities and Postnatal Growth Faltering in Preterm Neonates

Justyna Rogulska1,2, Tanis R Fenton3,4, Tomasz Szczapa1

  • 1II Department of Neonatology, Poznan University of Medical Sciences, 61-701 Poznan, Poland.

PubMed

Insights

Postnatal growth faltering (PGF) in preterm infants is linked to serious health issues like brain injury and lung disease. Early detection of PGF is crucial for interventions that can improve neurodevelopmental outcomes.

Area of Science:

  • Neonatology
  • Pediatric Growth and Development
  • Neurodevelopmental Pediatrics

Background:

  • Postnatal growth faltering (PGF) in very preterm neonates is a significant risk factor for adverse neurodevelopmental outcomes.
  • Understanding the specific factors associated with PGF is crucial for timely intervention.

Purpose of the Study:

  • To identify baseline characteristics, prenatal risk factors, and neonatal morbidities associated with two definitions of PGF: severe PGF (loss of >2 weight z-scores) and complex PGF (loss of >1 weight, length, and head circumference z-scores).

Main Methods:

  • Retrospective study of 146 premature newborns (<32 weeks gestational age, <1500 g).
  • Data extracted from clinical electronic database, including anthropometric measurements and perinatal/neonatal morbidities.
  • Changes in z-scores calculated using Fenton 2013 preterm growth charts to diagnose PGF.

Main Results:

  • Incidence of severe PGF was 11%, complex PGF was 24%.
  • Both PGF types associated with bronchopulmonary dysplasia, severe retinopathy of prematurity, longer respiratory support, and longer hospital stay.
  • Severe PGF linked to surgical necrotizing enterocolitis; complex PGF linked to severe brain injury.

Conclusions:

  • Both severe and complex PGF are associated with significant neonatal morbidities, potentially explaining links to suboptimal neurodevelopment.
  • Early identification of faltered growth may guide medical and nutritional interventions to improve outcomes for very preterm newborns.
Abstract

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.3K
Nature and Nurture01:10

Nature and Nurture

Many human characteristics, like height, are shaped by both nature—in other words, by our genes—and by nurture, or our environment. For example, chronic stress during childhood inhibits the production of growth hormones and consequently reduces bone growth and height. Scientists estimate that 70-90% of variation in height is due to genetic differences among individuals, and 10-30% of variation in height is due to differences in the environments that individuals experience,...
20.3K
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
124